Articles related to LIVER DISEASE

In patients with both cirrhosis and atrial fibrillation, apixaban initiation was associated with lower rates of major bleeding compared to rivaroxaban or warfarin, without compromising thromboembolic protection.

Incidence rates provide a truer measure of medication-induced liver injury, revealing misclassifications in traditional methods. This study highlights the need for closer monitoring of certain medications using real-world healthcare data.

A phase 2 trial found that tirzepatide, administered once weekly, significantly improved the resolution of MASH and fibrosis stages in patients with moderate to severe liver fibrosis. These results highlight tirzepatide’s potential as a treatment option, emphasizing the need for further research to validate these findings in larger, long-term studies.

Cardiac complications significantly influence the success of liver transplants. Effective preoperative cardiac risk stratification and careful intraoperative management are essential to optimize patient outcomes.

This analysis of a PBC patient’s complex lipid profile underscores the importance of diagnosing the specific types of xanthomas, as they are directly indicative of underlying dyslipidemias, which require tailored therapeutic approaches.

In the evolving landscape of liver disease management, timely diagnosis and tailored treatment strategies for ascites and spontaneous bacterial peritonitis stand as pivotal elements in enhancing patient survival and quality of life, underscoring the necessity of adherence to updated guidelines.